A critical appraisal of the value of immunohistochemistry in diagnosis of uterine neoplasms

Advances in Anatomic Pathology

Volumn 11, Issue 3, 2004, Pages 162-171

  McCluggage, W Glenn ^a  

^a ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

Author keywords

Endometrial carcinoma; Endometrial stromal neoplasm; Endometrium; Immunohistochemistry; Smooth muscle neoplasm; Uterus

Indexed keywords

ANTIBODY; DIAGNOSTIC AGENT;

ADENOCARCINOMA; CARCINOMA IN SITU; DIFFERENTIAL DIAGNOSIS; ENDOMETRIUM TUMOR; EVALUATION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; OVARY TUMOR; PATHOLOGY; REVIEW; SEX CORD TUMOR; STANDARD; UTERINE CERVIX TUMOR; UTERUS CANCER;

ADENOCARCINOMA; ANTIBODIES; CARCINOMA IN SITU; DIAGNOSIS, DIFFERENTIAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; OVARIAN NEOPLASMS; SEX CORD-GONADAL STROMAL TUMORS; UTERINE CERVICAL NEOPLASMS; UTERINE NEOPLASMS;

EID: 6944254408     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/00125480-200405000-00004     Document Type: Review

References (68)

1. McCluggage WG. Recent advances in immunohistochemistry in gynaecological pathology. Histopathology. 2002;40:309-326. (Pubitemid 34595581)
2. Wheeler DT, Bell KA, Kurman RJ, et al. Minimal uterine serous carcinoma: diagnosis and clinicopathologic correlation. Am J Surg Pathol. 2000;24:797-806. (Pubitemid 30366266)
3. Stewart RL, Royds JA, Burton JL, et al. Direct sequencing of the p53 gene shows absence of mutations in endometrioid endometrial adenocarcinoma expressing p53 protein. Histopathology. 1998;33:440-445. (Pubitemid 28529778)
4. Schlosshauer PW, Hedrick Ellenson L, Soslow RA. β-catenin and E-cadherin expression patterns in high-grade endometrial carcinoma are associated with histological subtype. Mod Pathol. 2002;15:1032-1037.
5. Silva EG, Jenkins R. Serous carcinoma in endometrial polyps. Mod Pathol. 1990;3:120-128.
6. Carcangiu ML, Tom LK, Chambers JT. Stage IA uterine serous carcinoma: a study of 13 cases. Am J Surg Pathol. 1997;21:1507-1514. (Pubitemid 27528263)
7. McCluggage WG, Sumathi VP, McManus DT. Uterine serous carcinoma and endometrial intraepithelial carcinoma arising in endometrial polyps: report of five cases including two associated with tamoxifen therapy. Hum Pathol. (in press).
8. Ambros RA, Sherman ME, Zahn CM, et al. Endometrial intraepithelial carcinoma: distinctive lesion specifically associated with tumors displaying serous differentiation. Hum Pathol. 1995;26:1260-1267.
9. McClugage WG, Sumathi VP, McBride HA, et al. A panel of immunohistochemical stains, including carcinoembryonic antigen, vimentin and estrogen receptors aids the distinction between primary endometrial and endocervical adenocarcinomas. Int J Gynecol Pathol. 2002;21:11-15. (Pubitemid 34008347)
10. Castrillon DH, Lee KR, Nucci MR. Distinction between endometrial and endocervical adenocarcinomas: an immunohistochemical study. Int J Gynecol Pathol. 2002;21:4-10. (Pubitemid 34008346)
11. Kamoi S, Al Juboury MI, Akin M-R, et al. Immunohistochemical staining in the distinction between primary endometrial and endocervical adenocarcinomas: another viewpoint. Int J Gynecol Pathol. 2002;21:217-223. (Pubitemid 34680337)
12. Staebler A, Sherman ME, Zairo RJ, et al. Hormone receptor immunohistochemistry and human papillomavirus in situ hybridization are useful for distinguishing endocervical and endometrial adenocarcinomas. Am J Surg Pathol. 2002;26:998-1006. (Pubitemid 34810560)
13. Czerwenka K, Lu YX, Heuss F, et al. Human papillomavirus detection of endometrioid carcinoma with squamous differentiation of the uterine corpus. Gynecol Oncol. 1996;61:210-214. (Pubitemid 26145725)
14. Fujita M, Shroyer KR, Markham NE, et al. Association of human papillomavirus with malignant and premalignant lesions of the uterine endometrium. Hum Pathol. 1995;26:650-658.
15. Keating JT, Cviko A, Reithdorf S, et al. Ki-67, cyclin E and p16 (INK4) are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am J Surg Pathol. 2001;25:884-891. (Pubitemid 32594981)
16. Klaes R, Friedrich T, Spitkovsky D, et al. Overexpression of p16 (INK 4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer. 2001;92:276-284. (Pubitemid 32225381)
17. Klaes R, Benner A, Friedrich T, et al. p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol. 2002;26:1389-1399. (Pubitemid 35239415)
18. Cameron RI, Maxwell P, Jenkins D, et al. Immunohistochemical staining with MIB1, bcl-2 and p16 assists in the distinction of cervical glandular intraepithelial neoplasia from tubo-endometrial metaplasia, endometriosis and microglandular hyperplasia. Histopathology. 2002;41:313-321. (Pubitemid 35279028)
19. Riethdorf L, Riethdorf S, Lee KR, et al. Human papillomaviruses, expression of p16 INK4A, and early endocervical glandular neoplasia. Hum Pathol. 2002;33:899-904.
20. McCluggage WG, Jenkins D. Immunohistochemical staining with p16 may assist in the distinction between endometrial and endocervical adenocarcinoma. Int J Gynecol Pathol. 2003;22:231-235.
21. Baergen RN, Warren CP, Isacson C, et al. Early uterine serous carcinoma: clonal origin of extrauterine disease. Int J Gynecol Pathol. 2001;20:214-219. (Pubitemid 32578105)
22. Shimizu M, Toki T, Takagi Y, et al. Immunohistochemical detection of the Wilm's tumor gene (WT1) in epithelial ovarian tumors. Int J Gynecol Pathol. 2000;19:158-163. (Pubitemid 30212153)
23. Goldstein NS, Uzieblo A. WT1 immunoreactivity in uterine papillary serous carcinoma is different from ovarian serous carcinomas. Am J Clin Pathol. 2002;117:541-545. (Pubitemid 34823682)
24. Al-Hussaini M, Stockman A, Foster H, et al. WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma. Histopathology. (in press).
25. Chu PG, Arber PA, Weiss LM, et al. Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases. Mod Pathol. 2001;14:465-471. (Pubitemid 32448746)
26. McCluggage WG, Sumathi VP, Maxwell P. CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms. Histopathology. 2001;39:273-278. (Pubitemid 34279662)
27. Oliva E, Young RH, Amin MB, et al. An immunohistochemical analysis of endometrial stromal and smooth muscle tumors of the uterus. A study of 54 cases emphasising the importance of using a panel because of overlap in immunoreactivity for individual antibodies. Am J Surg Pathol. 2002;26:403-412. (Pubitemid 34280112)
28. Ordi J, Nogales FF, Palacia A, et al. Mesonephric adenocarcinoma of the uterine corpus: CD10 expression as evidence of mesonephric differentiation. Am J Surg Pathol. 2001;25:1540-1545. (Pubitemid 33096970)
29. Ordi J, Romagosa C, Tavassoli FA, et al. CD10 expression in epithelial tissues and tumors of the gynecologic tract: A useful marker in the diagnosis of mesonephric, trophoblastic and clear cell tumors. Am J Surg Pathol. 2003;27:178-186. (Pubitemid 36152226)
30. McCluggage WG, Oliva E, Herrington CS, et al. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinoma of the uterine corpus. CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma. Histopathology. 2003;43:144-150. (Pubitemid 36963158)
31. Mikami Y, Hata S, Kiyokawa T, et al. Expression of CD10 in malignant Müllerian mixed tumors and adenosarcomas: an immunohistochemical study. Mod Pathol. 2002;15:923-930.
32. Zamecnik M. Letter to editor. Expression of CD10 in malignant Müllerian mixed tumors and adenosarcomas: an immunohistochemical study. Mod Pathol. 2003;16:618-619.
33. Sroden M, Klein WM, Kurman RJ. CD10 immunostaining does not distinguish endometrial carcinoma invading myometrium from carcinoma involving adenomyosis. Am J Surg Pathol. 2003;27:786-789. (Pubitemid 36617515)
34. Nascimento AF, Hirsh MS, Cviko A, et al. The role of CD10 staining in distinguishing invasive endometrial adenocarcinoma from adenocarcinoma involving adenomyosis. Mod Pathol. 2003;16:22-27. (Pubitemid 36152682)
35. Toki T, Shimizu M, Takagi Y, et al. CD10 is a marker for normal and neoplastic endometrial stromal cells. Int J Gynecol Pathol . 2002;21:41-47. (Pubitemid 34008352)
36. Young RH, Scully RE. Uterine carcinomas simulating microglandular hyperplasia. A report of six cases. Am J Surg Pathol. 1992;16:1092-1097.
37. Zaloudek C, Hayashi GM, Ryan IP, et al. Microglandular adenocarcinoma of the endometrium. A form of mucinous adenocarcinoma that may be confused with microglandular hyperplasia of the cervix. Int J Gynecol Pathol. 1999;16:52-59.
38. McCluggage WG, Perenyei M. Microglandular adenocarcinoma of the endometrium. Histopathology. 2000;37:285-287.
39. Jacques SM, Qureshi F, Lawrence WD. Surface epithelial changes in endometrial adenocarcinoma: diagnostic pitfalls in curettage specimens. Int J Gynecol Pathol. 1995;14:191-197.
40. Qiu W, Mittal K. Comparison of morphologic and immunohistochemical features of cervical microglandular hyperplasia with low nuclear grade mucinous adenocarcinoma of the endometrium. Int J Gynecol Pathol. 2003;22:261-265. (Pubitemid 36750408)
41. Lehman MB, Hart WR. Simple and complex hyperplastic papillary proliferations of the endometrium: a clinicopathologic study of nine cases of apparently localised papillary lesions with fibrovascular stromal cores and epithelial metaplasia. Am J Surg Pathol. 2001;25:1347-1354. (Pubitemid 33022049)
42. Lax SF, Pizer ES, Ronnett BM, et al. Clear cell carcinoma of the endometrium is characterised by a distinctive profile of p53, Ki-67, estrogen and progesterone receptor expression. Hum Pathol. 1998;29:551-558. (Pubitemid 28272707)
43. Quddas MR, Sung CJ, Zheny W, et al. p53 immunoreactivity in endometrial metaplasia with dysfunctional uterine bleeding. Histopathology. 1999;35:44-49. (Pubitemid 29325296)
44. Oliva E, Young RH, Clement PB, et al. Cellular benign mesenchymal tumors of the uterus: a comparative morphologic and immunohistochemical analysis of 33 highly cellular leiomyomas and seven endometrial stromal nodules, two frequently confused tumors. Am J Surg Pathol. 1995;19:757-768.
45. Oliva E, Clement PB, Young RH, et al. Mixed endometrial stromal and smooth muscle tumors of the uterus: a clinicopathologic study of 15 cases. Am J Surg Pathol. 1998;22:957-1005.
46. Scully RE. Smooth muscle differentiation in genital tract disorders. Arch Pathol Lab Med. 1981;105:505-507. (Pubitemid 11000114)
47. Oliva E, Young RH, Clement PB, et al. Myxoid and fibrous endometrial stromal tumors of the uterus. A report of 10 cases. Int J Gynecol Pathol. 1999;18:310-319. (Pubitemid 29489051)
48. Oliva E, Clement PB, Young RH. Epithelioid endometrial and endometrioid stromal tumors: a report of four cases emphasising their distinction from epithelioid smooth muscle tumors and other oxyphilic uterine and extrauterine tumors. Int J Gynecol Pathol. 2002;26:48-55. (Pubitemid 34008353)
49. Franquemont DW, Frierson HF Jr, Mills SE. An immunohistochemical study of normal endometrial stroma and endometrial stromal neoplasms: evidence for smooth muscle differentiation. Am J Surg Pathol. 1991;15:861-870.
50. Devaney K, Tavassoli FA. Immunohistochemistry as a diagnostic aid in the interpretation of unusual mesenchymal tumors of the uterus. Mod Pathol. 1991;4:225-231.
51. Farhood AI, Abrams J. Immunohistochemistry of endometrial stromal sarcoma. Hum Pathol. 1991;22:224-230.
52. Nucci MR, O'Connell JT, Huettner PC, et al. h-caldesmon expression effectively distinguishes endometrial stromal tumors from uterine smooth muscle tumors. Am J Surg Pathol. 2001;25:455-463. (Pubitemid 32240884)
53. Rash DS, Tan JY, Baergen RN, et al. h-caldesmon, a novel smooth muscle-specific antibody, distinguishes between cellular leiomyoma and endometrial stromal sarcoma. Am J Surg Pathol. 2001;25:253-258. (Pubitemid 32167508)
54. Agoff SN, Grieco VS, Garcia R, et al. Immunohistochemical distinction of endometrial stromal sarcoma and cellular leiomyoma. Appl Immuno Mol Morphol. 2001;9:164-169. (Pubitemid 32477204)
55. Toki T, Shimizu M, Takagi Y, et al. CD10 is a marker for normal and neoplastic endometrial stromal cells. Int J Gynecol Pathol. 2002;21:41-47. (Pubitemid 34008352)
56. McCluggage WG, Catherwood M, Alexander HD, et al. Immunohistochemical expression of CD10 and t(14;18) chromosomal translocation may be indicators of follicle centre cell origin in nodal diffuse large B-cell lymphoma. Histopathology. 2002;41:414-420.
57. Chu P, Arber DA. Paraffin-section detection of CD10 in 505 nonhematopoietic neoplasms. Frequent expression in renal cell carcinoma and endometrial stromal sarcoma. Am J Clin Pathol. 2000;113:374-382. (Pubitemid 30217385)
58. Konishi I, Fujii S, Okamura H, et al. Development of smooth muscle in the human fetal uterus: an ultrastructural study. J Anat. 1984;139:239-252. (Pubitemid 14029026)
59. Vang R, Kempson RL. Perivascular epithelioid cell tumor (PEComa) of the uterus: a subset of HMB45 positive epithelioid mesenchymal neoplasms with an uncertain relationship to pure smooth muscle tumors. Am J Surg Pathol. 2002;26:1-13. (Pubitemid 34019987)
60. Silva EG, Deavers MT, Bodurka D, et al. Uterine epithelioid leiomyosarcomas with clear cells or malignant PEComas? Mod Pathol. 2003;16:211.
61. Zamecnik M, Michel M. HMB45 + epithelioid tumor of the uterus is linked to epithelioid leiomyoma rather than PEComas. Int J Surg Pathol. 2001;9:341-343. (Pubitemid 34031153)
62. Clement PB, Scully RE. Uterine tumors resembling ovarian sex-cord tumors. A clinicopathologic analysis of fourteen cases. Am J Clin Pathol. 1976;66:512-525.
63. Oliva E, Clement PB, Young RH. Endometrial stromal tumors: an update on a group of tumors with a protean phenotype. Adv Anat Pathol. 2000;7:257-281.
64. Suzuki C, Matsumoto T, Fukunaga M, et al. Uterine tumors resembling ovarian sex-cord tumors producing parathyroid hormone-related protein of the uterine cervix. Pathol Int. 2002;52:164-168. (Pubitemid 34298105)
65. Kabbani W, Deavers MT, Malpica A, et al. Uterine tumor resembling ovarian sex-cord tumor: report of a case mimicking cervical adenocarcinoma. Int J Gynecol Pathol. 2003;23:297-302. (Pubitemid 36750415)
66. Krishnamurthy S, Jungbluth AA, Busam KJ, et al. Uterine tumors resembling ovarian sex-cord tumors have an immunophenotype consistent with true sex-cord differentiation. Am J Surg Pathol. 1998;22:1078-1082. (Pubitemid 28411065)
67. Baker RJ, Hildebrandt RH, Rouse RV, et al. Inhibin and CD99 (MIC2) expression in uterine stromal neoplasms with sex cord-like elements. Hum Pathol. 1999;30:671-679. (Pubitemid 29266727)
68. McCluggage WG. Uterine tumours resembling ovarian sex cord tumours: immunohistochemical evidence for true sex cord differentiation. Histopathology. 1999;34:375-376.